Skip to main content
Fig. 1 | BMC Nutrition

Fig. 1

From: Regulation of plasma lipid profile by lactobacillus fermentum (probiotic strain ME-3 DSM14241) in a randomised controlled trial of clinically healthy adults

Fig. 1

Flow chart of the study subjects. Legend: Randomised, double-blind, placebo-controlled, parallel-design, two-armed study (registered trial ISRCTN49744186). Participants were randomly assigned to receive either probiotic or placebo using a computer-generated randomisation list prepared by the independent statistician. The 164 eligible subjects were randomised to receive either probiotic treatment (PG; n = 83) or control kefir (CG; n = 81). The measurements were performed at 4 weeks with 137 participants (n = 71 PG and n = 66 CG) while 27 subjects withdrew. At 8 weeks 76 participants (n = 43 PG and n = 33 CG) were followed; while 51 subjects withdrew

Back to article page

BMC Nutrition

ISSN: 2055-0928

Contact us